Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 19, 2024

BUY
$9.97 - $14.52 $126,619 - $184,404
12,700 New
12,700 $180,000
Q4 2023

Feb 14, 2024

BUY
$9.97 - $14.52 $126,619 - $184,404
12,700 New
12,700 $180,000
Q1 2022

May 16, 2022

SELL
$7.89 - $12.48 $93,102 - $147,264
-11,800 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $103,132 - $139,712
11,800 New
11,800 $113,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.68B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.